Comparison of the Prognostic Value of Inflammation-Based Scores in Patients with Hepatocellular Carcinoma After Anti-PD-1 Therapy
出版年份 2021 全文链接
标题
Comparison of the Prognostic Value of Inflammation-Based Scores in Patients with Hepatocellular Carcinoma After Anti-PD-1 Therapy
作者
关键词
-
出版物
Journal of Inflammation Research
Volume Volume 14, Issue -, Pages 3879-3890
出版商
Informa UK Limited
发表日期
2021-08-11
DOI
10.2147/jir.s325600
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection
- (2020) Elisabeth S. Gruber et al. ANNALS OF SURGICAL ONCOLOGY
- mRECIST for HCC: Performance and novel refinements
- (2020) Josep M. Llovet et al. JOURNAL OF HEPATOLOGY
- Nutrition and metabolism status alteration in advanced hepatocellular carcinoma patients treated with anti-PD-1 immunotherapy
- (2020) Yizhen Jiang et al. SUPPORTIVE CARE IN CANCER
- Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in advanced hepatocellular carcinoma patients treated with anti–PD‐1 therapy
- (2020) Sirish Dharmapuri et al. Cancer Medicine
- Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma
- (2020) Bruno Sangro et al. JOURNAL OF HEPATOLOGY
- The Paradoxical Roles of Inflammation during PD-1 Blockade in Cancer
- (2020) Marcelo Hill et al. TRENDS IN IMMUNOLOGY
- Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody
- (2020) Mehmet Akce et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer
- (2019) Yoshinaga Okugawa et al. ANNALS OF SURGERY
- Albumin–globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancer
- (2019) Yu Nakanishi et al. International Journal of Clinical Oncology
- Emerging agents and regimens for hepatocellular carcinoma
- (2019) Xiao-Dong Zhu et al. Journal of Hematology & Oncology
- The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort
- (2019) Diane Damotte et al. Journal of Translational Medicine
- Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response
- (2019) Bridget P. Keenan et al. Journal for ImmunoTherapy of Cancer
- Combination of lymphocyte number and function in evaluating host immunity
- (2019) Ying Luo et al. Aging-US
- Blocking inflammation to improve immunotherapy of advanced cancer
- (2019) Antonio Macciò et al. IMMUNOLOGY
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- T lymphocyte subsets in cancer immunity: Friends or foes
- (2018) Dounia Chraa et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Targeting cancer-related inflammation in the era of immunotherapy
- (2017) Kyohei Nakamura et al. IMMUNOLOGY AND CELL BIOLOGY
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Prognostic value of neutrophil-to-lymphocyte ratio in advanced oesophago-gastric cancer: exploratory analysis of the REAL-2 trial
- (2016) T. Grenader et al. ANNALS OF ONCOLOGY
- Regulation of Transdifferentiation and Retrodifferentiation by Inflammatory Cytokines in Hepatocellular Carcinoma
- (2016) Florian Cabillic et al. GASTROENTEROLOGY
- Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
- (2016) Jordi Bruix et al. GASTROENTEROLOGY
- Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients
- (2016) Qing-Tao Zhao et al. INTERNATIONAL JOURNAL OF CANCER
- Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer
- (2015) Mitsuru Ishizuka et al. ANNALS OF SURGICAL ONCOLOGY
- The role of hepatic resection in the treatment of hepatocellular cancer
- (2015) Sasan Roayaie et al. HEPATOLOGY
- Inflammation and cancer: advances and new agents
- (2015) Shanthini M. Crusz et al. Nature Reviews Clinical Oncology
- Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma
- (2014) B. Hu et al. CLINICAL CANCER RESEARCH
- The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis
- (2014) Kaiyu Sun et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Cancer-related inflammation and treatment effectiveness
- (2014) Connie I Diakos et al. LANCET ONCOLOGY
- The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
- (2012) Donald C. McMillan CANCER TREATMENT REVIEWS
- An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study
- (2011) M J Proctor et al. BRITISH JOURNAL OF CANCER
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Profile of Tumor Antigen-Specific CD8 T Cells in Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma
- (2009) Adam J. Gehring et al. GASTROENTEROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started